Association between Circulation Indole-3-Acetic Acid Levels and Stem Cell Factor in Maintenance Hemodialysis

Ping-Hsun Wu1,2,3,4, Yi-Ting Lin1,2,4,5, Pei-Yu Wu1,3,6

  • 1Graduate Institute of Clinical Medicine, College of Medicines, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

Insights

Protein-bound uremic toxins like Indole-3-acetic acid (IAA) are cardiovascular risks in kidney disease patients. This study found IAA is linked to stem cell factor, suggesting a new pathway in cardiovascular disease development.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Protein-bound uremic toxins are established cardiovascular (CV) risk factors in end-stage renal disease patients.
  • Indole-3-acetic acid (IAA), a uremic toxin, is linked to CV disease, but its precise role is unclear.
  • Mitogen-activated protein kinase (MAPK) signaling pathways are implicated in CV disease pathogenesis.

Purpose of the Study:

  • To investigate the association between circulating Indole-3-acetic acid (IAA) levels and proteins within the MAPK signaling cascade in hemodialysis (HD) patients.
  • To explore potential pathophysiological mechanisms linking IAA to cardiovascular disease in kidney disease patients.

Main Methods:

  • Quantification of circulating total form IAA using mass spectrometry.
  • Measurement of forty MAPK cascade-associated proteins via proximity extension assay in 331 prevalent HD patients.
  • Multivariable-adjusted linear regression models and bioinformatics analysis (STITCH tool).

Main Results:

  • Circulating IAA levels showed a significant positive association with stem cell factor (SCF) (β = 0.13, p = 0.004) after adjusting for multiple testing.
  • Bioinformatics analysis suggested IAA's involvement in regulating cell proliferation, hematopoietic cells, and the JAK-STAT signaling pathway.
  • These findings highlight a potential novel mechanistic link between IAA and cardiovascular risk.

Conclusions:

  • Circulating IAA levels are associated with stem cell factor in hemodialysis patients, suggesting a novel pathway contributing to cardiovascular risk.
  • The findings provide insights into non-traditional cardiovascular risk factors in kidney disease.
  • Further in vitro studies are warranted to validate the identified mechanistic pathways.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
631
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
499